Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

IT stocks weigh on Indian stock markets
Wed, 15 Jun 09:30 am

Asian stock markets have opened the day on a mixed note. Stock markets in China (down 0.5%), Hong Kong (down 0.5%) and Taiwan (down 1%) are leading the losses. However, the markets in Indonesia (up 0.8%) and Malaysia (up 0.2%) are trading in the green. The Indian stock markets have opened the day in the red. Stocks in the IT and banking space are leading the losses. However, metal stocks are trading firm.

The BSE-Sensex is trading lower by around 52 points (0.3%), while the NSE-Nifty is down by about 16 points (0.3%). The midcap and smallcap stocks are trading marginally in the positive with both the BSE Midcap and BSE Small cap indices up by 0.1%. The rupee is trading at 44.72 to the US dollar.

IT stocks have opened the day on a weak note with Infosys, Tata Consultancy Services (TCS) and Wipro trading in the red. TCS, Asia's largest computer-services provider by value, hired 70,000 employees in the previous financial year. It plans to add another 60,000 employees in the current financial year. The main reason for such massive hiring has been robust demand for outsourcing IT services. Compared to about 41,000 employees 6 years back, the company had 198,614 employees as on 31st March, 2011. According to a report by NASSCOM (National Association of Software & Services Companies) dated 15th February, 2011, the IT industry employs about 2.5 m people. However, the boom in the industry has also translated into a huge problem for the sector in the form of attrition. The financial year ended March 2011 saw the IT majors such as TCS, Infosys and Wipro dealing with the highest ever annual attrition levels.

Pharma stocks have opened the day on a mixed note with Piramal Healthcare, Ranbaxy Labs and Sun Pharma trading in the green. However, Dr Reddy's Laboratories (DRL) and Biocon are facing selling pressure. DRL announced that one of its chemical facilities in Mexico has received a warning letter from the United States Food and Drug Authority (USFDA). This Mexican facility of DRL was inspected by USFDA at the end of 2010. The inspection led to the issuance of 'form FDA 483' which is issued with regards to non-compliance in manufacturing practices. It includes the detailed observations by USFDA with respect to non-compliance. The USFDA cited four major discrepancies in the manufacturing facility. However, DRL has stated that the company has responded to all the observations made by USFDA and will implement the changes immediately.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "IT stocks weigh on Indian stock markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.